In Memoriam: Dr. Rick van Saene (1946–2026) - Scorecard - MDSpire

In Memoriam: Dr. Rick van Saene (1946–2026)

  • By

  • Hans Rommes

  • Andy Petros

  • Durk Zandstra

  • Nia Taylor

  • Luciano Silvestri

  • Francisco Abecasis

  • April 27, 2026

  • 0 min

Share

Clinical Scorecard: Selective Decontamination of the Digestive Tract (SDD) in Intensive Care: Legacy of Dr. Rick van Saene

At a Glance

CategoryDetail
ConditionInfections in critically ill patients, sepsis, septic shock
Key MechanismsFour-component strategy targeting gut microorganisms to prevent infections
Target PopulationCritically ill patients, especially those with multiple trauma in intensive care units
Care SettingIntensive Care Units (ICUs) worldwide

Key Highlights

  • SDD is a four-component intervention designed to prevent infections by selectively decontaminating the digestive tract.
  • Over 45 years, SDD has been extensively researched with 73 randomized controlled trials and 16 meta-analyses supporting its efficacy and safety.
  • SDD is included in the 2026 Surviving Sepsis Campaign international guidelines for sepsis and septic shock management.

Guideline-Based Recommendations

Diagnosis

  • Identify critically ill patients at high risk of infection, particularly those with multiple trauma or sepsis.

Management

  • Implement the four-component SDD strategy to control infections and reduce mortality in ICU patients.
  • Incorporate SDD as part of standard care in intensive care units as recommended by the 2026 Surviving Sepsis Campaign guidelines.

Monitoring & Follow-up

  • Track infection rates and patient outcomes to assess the effectiveness of SDD implementation.
  • Critically evaluate emerging studies and meta-analyses related to SDD to ensure ongoing efficacy and safety.

Risks

  • Be aware of initial controversies and opposition from traditional microbiology perspectives.
  • Monitor for potential microbial resistance or unintended consequences, although studies support SDD safety.

Patient & Prescribing Data

Critically ill ICU patients, including those with multiple trauma and sepsis.

SDD has demonstrated a significant reduction in infection rates and mortality, supported by extensive randomized trials and meta-analyses.

Clinical Best Practices

  • Adopt a multidisciplinary approach involving microbiologists and intensive care specialists for SDD implementation.
  • Maintain rigorous scientific scrutiny and critical appraisal of all studies related to SDD.
  • Educate and train ICU staff on the principles and application of the SDD strategy.
  • Encourage ongoing research and collaboration to optimize SDD protocols and patient outcomes.

References

Original Source(s)

Related Content